High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand.

Article Details

Citation

Cheng R, Felicetti B, Palan S, Toogood-Johnson I, Scheich C, Barker J, Whittaker M, Hesterkamp T

High-resolution crystal structure of human Mapkap kinase 3 in complex with a high affinity ligand.

Protein Sci. 2010 Jan;19(1):168-73. doi: 10.1002/pro.294.

PubMed ID
19937655 [ View in PubMed
]
Abstract

The Mapkap kinases 2 and 3 (MK2 and MK3) have been implicated in intracellular signaling pathways leading to the production of the pro-inflammatory cytokine tumor necrosis factor alpha. MK2 has been pursued by the biopharmaceutical industry for many years for the development of a small molecule anti-inflammatory treatment and drug-like inhibitors have been described. The development of some of these compounds, however, has been slowed by the absence of a high-resolution crystal structure of MK2. Herein we present a high-resolution (1.9 A) crystal structure of the highly homologous MK3 in complex with a pharmaceutical lead compound. While all of the canonical features of Ser/Thr kinases in general and MK2 in particular are recapitulated in MK3, the detailed analysis of the binding interaction of the drug-like ligand within the adenine binding pocket allows relevant conclusions to be drawn for the further design of potent and selective drug candidates.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
MAP kinase-activated protein kinase 3Q16644Details